Triple positivity for anti–citrullinated protein autoantibodies, rheumatoid factor, and anti–carbamylated protein antibodies conferring high specificity for rheumatoid …
…, MAM van Delft, JD Jones, WFC Rigby… - Arthritis & …, 2018 - Wiley Online Library
Objective In rheumatoid arthritis ( RA ), anti–citrullinated protein antibodies ( ACPA s) and
rheumatoid factor ( RF ) are commonly used to aid in the diagnosis. Although these …
rheumatoid factor ( RF ) are commonly used to aid in the diagnosis. Although these …
The formation of controlled-porosity membranes from anodically oxidized aluminium
RC Furneaux, WR Rigby, AP Davidson - Nature, 1989 - nature.com
Synthetic membranes are used in a number of diverse applications, such as filtration 1,2 ,
bioreactors 2,3 , tissue culture 4 , analytical devices including sensors 2,5 , and as supports for …
bioreactors 2,3 , tissue culture 4 , analytical devices including sensors 2,5 , and as supports for …
Effect of tocilizumab on neutrophils in adult patients with rheumatoid arthritis: pooled analysis of data from phase 3 and 4 clinical trials
Objectives. To investigate changes in neutrophil count and occurrences of infection in RA
patients treated with the IL-6 receptor-α inhibitor tocilizumab (TCZ). Methods. Data were …
patients treated with the IL-6 receptor-α inhibitor tocilizumab (TCZ). Methods. Data were …
Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol).
WF Rigby, T Stacy, MW Fanger - The Journal of clinical …, 1984 - Am Soc Clin Investig
Recent studies have suggested that vitamin D may have other important biologic activities in
addition to its well-characterized role in the maintenance of calcium homeostasis. Discovery …
addition to its well-characterized role in the maintenance of calcium homeostasis. Discovery …
The immunobiology of vitamin D.
WFC Rigby - 1988 - cabidigitallibrary.org
As well as being responsible for calcium metabolism, calcitriol, the most active member of
the vitamin D group, interacts extensively with the immune system. The role of calcitriol in the …
the vitamin D group, interacts extensively with the immune system. The role of calcitriol in the …
Regulation of lymphokine production and human T lymphocyte activation by 1, 25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA.
WF Rigby, S Denome, MW Fanger - The Journal of clinical …, 1987 - Am Soc Clin Investig
The steroid hormone, 1 alpha,25-dihydroxyvitamin D3 (calcitriol), has been shown to inhibit
T cell proliferation, primarily through inhibition of interleukin 2 (IL-2) production. In these …
T cell proliferation, primarily through inhibition of interleukin 2 (IL-2) production. In these …
MK2‐induced tristetraprolin: 14‐3‐3 complexes prevent stress granule association and ARE‐mRNA decay
…, T Stubbs, N Kedersha, S Wax, WFC Rigby… - The EMBO …, 2004 - embopress.org
Stress granules (SGs) are dynamic cytoplasmic foci at which stalled translation initiation
complexes accumulate in cells subjected to environmental stress. SG‐associated proteins such …
complexes accumulate in cells subjected to environmental stress. SG‐associated proteins such …
Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid …
Objectives This phase III study evaluated the efficacy and safety of rituximab plus methotrexate
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response …
(MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate response …
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
PP Tak, WF Rigby, A Rubbert-Roth… - Annals of the …, 2011 - ard.bmj.com
Objectives Rituximab is an effective treatment in patients with established rheumatoid arthritis
(RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the …
(RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the …
[HTML][HTML] Tofacitinib for psoriatic arthritis in patients with an inadequate response to TNF inhibitors
D Gladman, W Rigby, VF Azevedo… - … England Journal of …, 2017 - Mass Medical Soc
Background Tofacitinib is an oral Janus kinase inhibitor that is under investigation for the
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic arthritis …
treatment of psoriatic arthritis. We evaluated tofacitinib in patients with active psoriatic arthritis …